Table 3.
Any reported symptom | Eyea | Throatb | Nosec | Chestd | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yes/total | % | P (- test) | Yes/total | % | P (- test) | Yes/total | % | P (- test) | Yes/total | % | Yes/total | % | |
FA | 5/18 | 28 | – | 3/18 | 17 | ref | 2/18 | 11 | ref | 1/18 | 6 | 0/18 | 0 |
HVONOx | 12/19 | 63 | 0.031 | 7/19 | 37 | 0.27 e | 8/19 | 42 | 0.062e | 2/19 | 11 | 1/19 | 5 |
HVOPM+NOx | 14/18 | 78 | 0.003 | 8/18 | 44 | 0.07 | 9/18 | 50 | 0.011 | 5/18 | 28 | 3/18 | 17 |
Descriptive table of the number of volunteers reporting any type of symptoms, symptoms categorized by type, and χ2-tests for any reported symptoms, eye and throat symptoms. The -tests are compared to the FA exposure. χ2-tests were not performed for nose and chest symptoms due to the low number of reported symptoms. The number of subjects was 19 for HVONOx and 18 for FA and HVOPM+NOx
aItching, running and/or sore eyes. bSore/dry/irritated throat. cRunning nose and/or nose congestion. dChest tightness/breathlessness. ep values obtained from Fisher exact test